GLI1 and pancreatic neoplasm: For example, GANT61 demonstrated a GLI-specific antitumor activity in lung carcinoma xenograft model [102], acute myeloid leukemia [103], rhabdomyosarcoma [104], neuroblastoma [105], breast cancer [106], and pancreatic cancer [101].